Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma
Refining the Molecular Progression From Intraductal to Invasive Pancreatic Cancer: Correlating Genetic Profiles and Clinicopathological Phenotypes in Sporadic and Familial Pancreatic Adenocarcinoma
1 other identifier
observational
5
1 country
1
Brief Summary
The research purpose of this project is to create a registry, and blood and tissue bank for individuals at high-risk for pancreatic cancer. We plan to conduct histopathological and molecular analysis of resected pancreatic tissue prospectively collected from a cohort of pancreatic cancer patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 18, 2009
CompletedFirst Submitted
Initial submission to the registry
October 11, 2010
CompletedFirst Posted
Study publicly available on registry
October 13, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 27, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 27, 2021
CompletedJune 11, 2021
June 1, 2021
12.1 years
October 11, 2010
June 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of subjects with histological features of PanIN lesions assessed
Distinctive histological features of PanIN within surgical specimens of our two study groups will be assessed by pathologists.
1 year
Secondary Outcomes (2)
Evaluation of clonality multifocal PanIN lesions
1 year
Evaluation of Recurrence Mechanism in PDC
1 year
Study Arms (2)
Family History patients
Patients with a strong family history of pancreatic cancer or with a genetic syndrome that puts them at risk for pancreas cancer.
Recurrence patients
Patients who underwent surgery for pancreatic cancer and developed tumor recurrence after surgery
Eligibility Criteria
Patients who are identified by a clinician as having either 1) a strong family history of pancreatic cancer; or 2) evidence (radiological or pathological) of local tumor recurrence following surgical resection, will be included in the study.
You may qualify if:
- Tissue-confirmed diagnosis of pancreatic adenocarcinoma.
- Underwent surgical resection for adenocarcinoma at Columbia-Presbyterian Medical Center with pathologically negative surgical margins.
- Enrolled in our Pancreatic Cancer Registry and Tissue Bank protocol (AAAA-6154).
- Have at least 2 relatives (of whom one must be first-degree relative) with pancreatic cancer, or have been diagnosed with a a genetic syndrome which is associated with pancreatic cancer (among the included syndromes include BRCA1/2, FAMMM, Peutz-Jeghers, HNPCC, Hereditary Pancreatitis) -OR- Have radiological or pathological (fine needle aspirate or surgical biopsy) evidence of local tumor recurrence following surgery.
You may not qualify if:
- Metastatic disease discovered at presentation or on recurrence (exception is the familial PDC patients)
- Positive surgical margins.
- Lack of clinical followup at one year following surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Columbia Universitylead
- Cold Spring Harbor Laboratorycollaborator
Study Sites (1)
Columbia University Irving Medical Center
New York, New York, 10032, United States
Biospecimen
* Blood samples * Specimens of tumors, pre-cancerous lesions, and normal tissue from patients who need to have endoscopy or surgery for diagnosis or treatment of tumors that develop * Samples of urine and stool, and duodenal aspirates if an individual will be having an endoscopy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wendy K Chung, MD
Columbia University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 11, 2010
First Posted
October 13, 2010
Study Start
March 18, 2009
Primary Completion
April 27, 2021
Study Completion
April 27, 2021
Last Updated
June 11, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share